Abstracts Archive - Page 2291 of 2607 - ACR Meeting Abstracts

Abstract Number: 2142 • 2013 ACR/ARHP Annual Meeting
Long-Term Safety and Efficacy Of Subcutaneous Tanezumab In Patients With Knee Or Hip Osteoarthritis (NCT00994890)
Leslie Tive¹, Eugene J. Dabezies², Robert J. Fountaine³, Mark T. Brown³, Michael D. Smith³, Kenneth M. Verburg³ and Christine R. West⁴, ¹Arthritis, Pfizer Inc, New York, NY, ²Pensacola Research Consultants, Pensacola, FL, ³Pfizer, Inc., Groton, CT, ⁴Clinical Sciences, Pfizer, Williamston, MI
Background/Purpose : Tanezumab (TNZ), a monoclonal antibody that inhibits nerve growth factor, reduces hip or knee osteoarthritis (OA) pain. A non-controlled, randomized, double-blind study of…
Abstract Number: 2143 • 2013 ACR/ARHP Annual Meeting
Strontium Ranelate Significantly Decreases Radiological Progression Using a New Definition For Radiological Progression In Patients With Primary Knee Osteoarthritis Treated With Strontium Ranelate
Olivier Bruyere¹, Roland Chapurlat², Cyrus Cooper³ and Jean-Yves Reginster¹, ¹Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium, ²INSERM UMR 1033 and University of Lyon, Hôpital Edouard Herriot, Lyon, France, ³MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom
Strontium ranelate significantly decreases radiological progression using a new definition for radiological progression in patients with primary knee osteoarthritis treated with strontium ranelate Background/Purpose: Strontium…
Abstract Number: 2144 • 2013 ACR/ARHP Annual Meeting
Prevention Of Radiological Progression In Patients With Primary Knee Osteoarthritis With Strontium Ranelate
Jean-Yves Reginster¹, Roland Chapurlat², Francis Berenbaum³, P. Nash⁴, O. Zamani⁵, Martine Cohen-Solal⁶, Gerolamo Bianchi⁷, Jaime Branco⁸, F. Navarro⁹ and Cyrus Cooper¹⁰, ¹Department of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium, ²INSERM UMR 1033 and University of Lyon, Hôpital Edouard Herriot, Lyon, France, ³Rheumatology, AP-HP, St Antoine Hospital, Paris, France, ⁴University of Queensland, Brisbane, Australia, ⁵Rheumazentrum Favoriten, Wien, Austria, ⁶Rhumatologie A, INSERM U606 Hôpital Lariboisière, Centre Viggo Petersen, Paris, France, ⁷Div Reumatologia, ASL3 Genovese, Genoa, Italy, ⁸UNL/Rheumatology Department, Centro Hospitalar de Lisboa Ocidental, Hospital Egas Moniz, Lisboa, Portugal, ⁹UGC de Reumatologia, University Hospital Virgen Macarena, Sevilla, Spain, ¹⁰MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, United Kingdom
Prevention of radiological progression in patients with primary knee osteoarthritis with Strontium Ranelate Background/Purpose: Strontium ranelate (SrRan) has demonstrated a structure-modifying activity with symptomatic improvement in…
Abstract Number: 2145 • 2013 ACR/ARHP Annual Meeting
Impact On Cartilage Volume Changes Over Time Of Conventional Treatment and Of Glucosamine and Chondroitin Sulfate In Knee Osteoarthritis Patients: Data From The Osteoarthritis Initiative Cohort
Johanne Martel-Pelletier¹, Camille Roubille¹, Jean-Pierre Raynauld¹, François Abram², Pierre Dodin³, Marc Dorais⁴, Philippe Delorme¹ and Jean-Pierre Pelletier¹, ¹Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Montreal, QC, Canada, ²Medical Imaging Research & Development, ArthroLab Inc., Montreal, QC, Canada, ³Imaging Research & Development, ArthroLab Inc., Montreal, QC, Canada, ⁴StatSciences Inc., Notre-Dame de l’Île Perrot, QC, Canada
Background/Purpose: To explore, using data from participants enrolled in the progression cohort of the Osteoarthritis Initiative (OAI), the effects of conventional knee osteoarthritis (OA) pharmacological…
Abstract Number: 2146 • 2013 ACR/ARHP Annual Meeting
Effects Of Chondroitin Sulfate On Brain Response To Painful Stimulation In Knee Osteoarthritis Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Jordi Monfort¹, Jesús Pujol², O Contreras-Rodriguez², Jone Llorente-Onaindia², M López-Solà², Laura Blanco-Hinojo², J Deus², H Ortiz², Francisco Montañés³, M Campillo², Pere Benito², Laura Sánchez⁴, Marta Herrero⁵ and Josep Vergés⁶, ¹Reumatologia, Hospital del Mar, Barcelona, Spain, ²Hospital del Mar, Barcelona, Spain, ³Rhaumatology, Hospital del Mar, Barcelona, Spain, ⁴Bioiberica, Barcelona, Spain, ⁵Pharmascience Division, Bioiberica S.A., Barcelona, Spain, ⁶Pre-Clinical R&D Area, Pharmascience Division, BIOIBERICA S.A., Barcelona, Spain
Background/Purpose: Knee osteoarthritis (OA) is a degenerative joint disease causing symptoms in 12% of people over the age of 65 . A variety of treatments…
Abstract Number: 2147 • 2013 ACR/ARHP Annual Meeting
Effect Of Fish Oil On Structural Progression In Knee Osteoarthritis: A Two Year Randomized, Double-Blind Clinical Trial Comparing High Dose With Low Dose
Catherine L. Hill¹, Graeme Jones², Susan Lester³, Ruth Battersby¹, Tanya Fedorova⁴, Kristen Hynes⁵, Susanna Proudman⁶, Leslie G. Cleland⁶ and Lyn March⁷, ¹Rheumatology Unit, The Queen Elizabeth Hospital, Woodville, Australia, ²Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart,7000, Australia, ³Rheumatology Unit, Queen Elizabeth Hospital, Woodville South, Australia, ⁴Rheumatology Royal North Shore Hospital, University of Sydney Institute of Bone and Joint Research, St Leonards, Australia, ⁵Menzies Research Institute Tasmania, University of Tasmania, Hobart, Australia, ⁶Rheumatology Unit, Royal Adelaide Hospital, Adelaide, Australia, ⁷Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia
Background/Purpose: Fish oil is widely used for the symptomatic treatment of osteoarthritis. However, its effect on cartilage volume has not previously been investigated in an…
Abstract Number: 2148 • 2013 ACR/ARHP Annual Meeting
Use Of Low Dose Aspirin Is Associated With Reduced Medial Tibial Cartilage Loss In Symptomatic Osteoarthritis: DATA From A Cohort Study
Anita Wluka¹, Changhai Ding², Yuanyuan Wang³, Graeme Jones⁴, Andrew Teichtahl⁵ and Flavia Cicuttini¹, ¹Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia, ²Musculoskeletal Unit, Menzies Research Institute Tasmania, University of Tasmania, Hobart,7000, Australia, ³Monash University, Melbourne, Australia, ⁴Menzies Research Institute Tasmania, University of Tasmania, HOBART, Australia, ⁵Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
Background/Purpose: Inflammation and vascular disease have recently been shown to play a role in the pathogenesis of osteoarthritis (OA). Low dose aspirin is commonly used…
Abstract Number: 2125 • 2013 ACR/ARHP Annual Meeting
Comparison Of The Effectiveness Of Local Anesthetic and Corticosteroid Injections For The Treatment Of Piriformis Syndrome
Tugce Ozekli Misirlioglu, Kenan Akgun, Meryem Gul Erden and Tuba Erbilir, Physical Medicine and Rehabilitation, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey
Background/Purpose: Piriformis syndrome (PS), which is characterized by pain radiating to gluteal region and posterior leg, is accepted as one of the causes of sciatica.…
Abstract Number: 2109 • 2013 ACR/ARHP Annual Meeting
Quality Indicators For Physical Therapy Management In Hip and Knee Osteoarthritis and Rheumatoid Arthritis
Wilfred FH Peter^1,2, Emalie Hurkmans³, Philip van der Wees⁴, Erik Hendriks⁵, Rob de Bie⁵, Leti van Bodegom-Vos⁶ and Theodora P.M. Vliet Vlieland⁷, ¹Departmentof Orthopaedics, Leiden University Medical Center, Leiden, Netherlands, ²Amsterdam Rehabilitation Research Center, Reade, centre for rehabilitation and rheumatology, Amsterdam, Netherlands, ³Section Physiotherapy, University of Applied Sciences, Vienna, Austria, ⁴IQ Healthcare, Radboud University, Nijmegen, Netherlands, ⁵Centre for Evidence Based Physiotherapy, University of Maastricht, Maastricht, Netherlands, ⁶Department of Medical Decision Making, Leiden University Medical Center, Leiden, Netherlands, ⁷Department of Orthopaedics, Leiden University Medical Center, Leiden, Netherlands
Background/Purpose: Physical therapy is recommended in several guidelines on the management of osteoarthritis and rheumatoid arthritis. Currently, no specific quality indicators for physical therapy in…
Abstract Number: 2110 • 2013 ACR/ARHP Annual Meeting
Who Will Achieve Individually Set Goals After Arthritis Team Rehabilitation?
Sofia Hagel¹, Elisabet Lindqvist² and Ann B. I. Bremander³, ¹Department of Clinical Sciences Lund, Section for Rheumatology, Lund, Lund University and Skåne University Hospital, Lund, Sweden, ²Department of Clinical Sciences, Lund, Section for Rheumatology, Lund, Lund University and Skåne University Hospital, Lund, Sweden, ³Department of Clinical Sciences, Lund, Section of Rheumatology, Lund, Lund University, Lund, Sweden
Background/Purpose: To study goal achievement among patients with chronic inflammatory arthritis after arthritis rehabilitation performed in multidisciplinary team rehabilitation programs. Methods: 146 consecutive patients with…
Abstract Number: 2111 • 2013 ACR/ARHP Annual Meeting
The Impact Of Centralized Pain On Long-Term Analgesic Response To Lower Extremity Joint Arthroplasty: A Prospective, Observational Cohort Study
Chad M. Brummett¹, Andrew Urquhart², Brian Hallstrom², Alex Tsodikov³, David A. Williams⁴ and Daniel J. Clauw⁵, ¹Department of Anesthesiology, University of Michigan Medical School, Ann Arbor, MI, ²Orthopedics, University of Michigan Health System, Ann Arbor, MI, ³Biostatistics, School of Public Health, University of Michigan, Ann Arbor, MI, ⁴Chronic Pain & Fatigue Rsch Ctr, Univ of MI Hlth System-Lobby M, Ann Arbor, MI, ⁵Anesthesiology/Internal Medicine (Rheum), University of Michigan, Ann Arbor, MI
Background/Purpose : In cross-sectional studies, depression and pain in other locations have been reported as predicting poorer outcomes following total knee and hip arthroplasty. These…
Abstract Number: 2112 • 2013 ACR/ARHP Annual Meeting
Hip and Knee Arthroplasty In Patients With Rheumatoid Arthritis: Results From The Australian Orthopaedic Association National Joint Replacement Registry: 2003 To 2011
Andrew Lim¹, Stephen Graves², Yen Liu², Lionel Schachna¹ and Russell R. Buchanan¹, ¹Rheumatology, Austin Health, Melbourne, Australia, ²Australian Orthopaedic Association National Joint Replacement Registry, Adelaide, Australia
Background/Purpose: Total Joint Replacement in rheumatoid arthritis (RA) patients is a marker of disease severity. Whilst the rate of total hip (THA) and total knee…
Abstract Number: 2113 • 2013 ACR/ARHP Annual Meeting
Glucosamine–Chondroitin Sulfate Reduces Pain, Disability and Non-Steroidal Anti-Inflammatory Drug consumption In Patients With Chronic Low Back Pain: A Large, Community-Based, Pilot, Open Prospective Study
Gurkirpal Singh^1,2, Liudmila Alekseeva³, Valeriy Alekseev⁴ and Evgeny Nasonov⁵, ¹ICORE, Woodside, CA, ²Gastroenterology/Hepatology, Stanford University School of Medicine, Palo Alto, CA, ³State Institute of Rheumatology of Russian Academy of Medical Sciences, Moscow, Russia, ⁴Department of Nervous Diseases, First Moscow State Medical University, Moscow, Russia, ⁵State NII of Rheumatology of Russian Academy of Sciences, Moscow, Russia
Background/Purpose: The Global Burden of Diseases, Injuries, and Risk Factors Study 2010 identified low back pain as the leading cause of Years Lived with Disability…
Abstract Number: 2114 • 2013 ACR/ARHP Annual Meeting
Hip Fracture Risk Factors To One Year and In-Hospital Mortality , a Prospective Cohort In South Brazil
Tiango Aguiar Ribeiro^1,2, Melissa Orlandin Premaor^2,3, João Alberto Larangeira¹, Michel Luft^1,2, Luiz Giulian Brito¹, Leonardo Waihrich Guterres¹ and Odirlei Andre Monticielo⁴, ¹Department of Orthopedic Surgery and Traumatology, University Hospital of Santa Maria (SOT - HUSM), Federal University of Santa Maria (UFSM), Santa Maria, Brazil, ²Postgraduate Program in Health Sciences, Federal University of Santa Maria (UFSM), Santa Maria, Brazil, ³Department of Clinical Medicine Health Sciences Center (CCS), Federal University of Santa Maria (UFSM), Santa Maria, Brazil, ⁴Department of Internal Medicine, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
Background/Purpose: Hip fractures is considered one of the most common and serious injury in the elderly life and have been associated with increased morbidity and…
Abstract Number: 2115 • 2013 ACR/ARHP Annual Meeting
Social Networks and Hip Replacement Outcomes In Rheumatoid Arthritis and Osteoarthritis
Danielle Ramsden-Stein¹, Wei-Ti Huang^2,3, Rebecca Zhu⁴, Susan M. Goodman¹, Mark P. Figgie⁵, Michael Alexiades⁶ and Lisa A. Mandl¹, ¹Rheumatology, Hospital for Special Surgery, New York, NY, ²Biostatistics, Hospital for Special Surgery, New York, NY, ³Biostatistics, Hospital For Special Surgery, New York, NY, ⁴Clinical Research, Hospital for Special Surgery, New York, NY, ⁵Orthopedics, Hospital for Special Surgery, New York, NY, ⁶Orthopaedics, Hospital for Special Surgery, New York, NY
Background/Purpose: Social isolation is an independent risk factor for poor health outcomes. It is unknown if the degree of social isolation differs between RA and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].